Very healthy H1 report
With IT investments in place 24% increase in revenue saw a significant chunk falling through to the bottom line leading to a 100% increase in net profit after tax. In keeping with a trend of returning excess cash to shareholders they have increased the intrim dividend 80% to 4.5 cents (unfranked) and also authorised a share buyback of up to 10% of the register.
Profit appears to be trending toward the upper end of the 1.4 - 1.7m guided for the full year.
Cash on hand of 2m. No Debt.
Basically primary business provides a billing service to medical professionals in the UK.
- Steady organic revenue growth (~10% p.a)
- Dip in profits in last couple of years attributiable to pound depreciation and restructuring costs which seem to have been actually "one off" --> now returning to profit growth
- Now leveraging exposure to doctor's to sell other services e.g. insurance
- Good history of returning excess cash to shareholders and steady share count
- No debt
- 2mil in bank
Trading at foward PE of 11-14 on company projections representing good value IMHO